Rhythm Pharmaceuticals (RYTM) Market Cap 2017–2026

As of October 29, 2026, Rhythm Pharmaceuticals had a market cap of $6.405 billion, which increased by 1.20% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Rhythm Pharmaceuticals logo

Rhythm Pharmaceuticals, Inc. (RYTM)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$6.405B ▲ 1.20%
Start of 2026
$7.143B ▼ 10.33%
1 Year Ago
$7.455B ▼ 14.08%
All-Time High
$8.093B ▼ 20.86%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Rhythm Pharmaceuticals Market Cap History by Year and Month

Rhythm Pharmaceuticals Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$6.405B▼ 10.33%
$6.405B▼ 2.24%
$6.552B▼ 10.30%
$7.304B▲ 7.52%
$6.793B▼ 10.61%
$7.599B▲ 25.54%
$6.053B▲ 8.95%
$5.556B▼ 6.45%
$5.939B▼ 4.02%
$6.188B▼ 9.56%
$6.842B▼ 4.21%
2025$7.143B▲ 104.49%
2024$3.493B▲ 28.56%
2023$2.717B▲ 65.57%
2022$1.641B▲ 226.89%
All market cap values reflect closing prices for the period shown.

📊 Rhythm Pharmaceuticals Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:


Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.